Biobanking Market Report 2024-2034

Overall world revenue for Biobanking Market, 2024 to 2034 in terms of value the market will surpass US$75.0 billion in 2024, the work calculates. The publisher predicts strong revenue growth through to 2034. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Biobanking Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Investments and Funding Projected to Boost Industry Growth

Biobanks are experiencing increased acknowledgment and support from global governments, research bodies, and financial institutions, leading to a surge in investment in these facilities. Notably, initiatives like the Biorepository and Precision Medicine Initiative Cohort Program, funded by the U.S. National Institutes of Health (NIH), seek to amass biological samples from over a million individuals to establish a comprehensive national research resource. Concurrently, the European Commission has committed funding to the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), a pan-European facility focused on biobanking and biomolecular resources. This heightened attention and financial backing underscore the strategic importance of biobanks in advancing scientific research and precision medicine on a global scale.

Hight Cost of Equipment Likely to Challenge Industry Growth

The market's growth potential is anticipated to face limitations due to the substantial expenses associated with automated equipment. While cutting-edge technologies like advanced sample handling systems have the potential to enhance operational efficiency and elevate the quality of biobanking processes, their high price tags pose a considerable challenge, particularly for smaller biobanking enterprises or those with constrained financial capacities. Take, for instance, the expenditure involved in acquiring an automated storage system, which can vary based on its size and complexity. The initial capital outlay for such systems can be substantial, ranging from tens of thousands to hundreds of thousands of dollars. Beyond the initial investment, ongoing considerations encompass maintenance and operational expenses, including software updates, repairs, and training. This cost factor serves as a strategic consideration for businesses evaluating the incorporation of automated equipment in their biobanking operations.

What Questions Should You Ask before Buying a Market Research Report?

How is the biobanking market evolving?
What is driving and restraining the biobanking market?
How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each biobanking submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the biobanking projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of biobanking projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the biobanking market?
Where is the biobanking market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biobanking market today, and over the next 10 years:

The 264-page report provides 121 tables and 182 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Ownership

National/Regional Agencies
Universities
Non-profit
Private

Product and Service

Equipment
Consumables
Services
Software

Sample

Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Others

Application

Regenerative Medicine
Life Science Research
Clinical Research

End-users

Pharmaceutical & Biotechnology Companies
CROs
Academic & Research Institutes
Hospitals

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.
Canada

Europe

Germany
UK
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

Japan
China
India
Australia
South Korea
South-East Asia
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

MEA

GCC
South Africa
Rest of MEA

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

ASKION GmbH
Avantor Inc.
Azenta Inc.
Boca Biolistics
BIOIVT & ELEVATING SCIENCE
Cryoport Inc.
CTI Biotech
Hamilton Company
Isenet Biobanking
Merck & Co., Inc.
PHC Holdings Corporation
ProteoGenex Inc.
Qiagen N.V.
Thermo Fisher Scientific, Inc.
Tecan Trading AG
US Biolab Corp. Inc.

How will the Biobanking Market, 2024 to 2034 report help you?

In summary, the 260+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Biobanking Market 2024 to 2034, with forecasts for ownership, product and service, sample, application, end-users each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Biobanking Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 16 of the major companies involved in the Biobanking Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Biobanking Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

1 Report Overview

1.1 Objectives of the Study
1.2 Introduction to Biobanking Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher

2 Executive Summary

3 Market Overview

3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increased Focus on Precision Medicine and Genetic Testing
3.2.1.2 Growing Demand for Umbilical Cord Blood Banking
3.2.1.3 Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
3.2.2 Market Restraining Factors
3.2.2.1 Private Sponsorship Has Raised a Number of Ethical Issues
3.2.2.2 Issues Related to Biospecimen Sample Procurement
3.2.2.3 Long-term Sustainability of Biobanks
3.2.3 Market Opportunities
3.2.3.1 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
3.2.3.2 Opportunities for Cardiovascular Research
3.2.3.3 Growing Focus on the R&D of Cell Therapies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Biobanking Market Analysis by Ownership

4.1 Key Findings
4.2 Ownership Segment: Market Attractiveness Index
4.3 Biobanking Market Size Estimation and Forecast by Ownership
4.4 National/Regional Agencies
4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Universities
4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Non-profit
4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Private
4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Biobanking Market Analysis by Sample

5.1 Key Findings
5.2 Sample Segment: Market Attractiveness Index
5.3 Biobanking Market Size Estimation and Forecast by Sample
5.4 Blood Products
5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Human Tissues
5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Nucleic Acids
5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Cell Lines
5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Biological Fluids
5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Others
5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2024 & 2034 (%)

6 Biobanking Market Analysis by Application

6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Biobanking Market Size Estimation and Forecast by Application
6.4 Regenerative Medicine
6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Life Science Research
6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Clinical Research
6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2024 & 2034 (%)

7 Biobanking Market Analysis by Product and Service

7.1 Key Findings
7.2 Product and Service Segment: Market Attractiveness Index
7.3 Biobanking Market Size Estimation and Forecast by Product and Service
7.4 Equipment
7.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Consumables
7.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2024 & 2034 (%)
7.6 Services
7.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
7.6.2 Market Share by Region, 2024 & 2034 (%)
7.7 Software
7.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
7.7.2 Market Share by Region, 2024 & 2034 (%)

8 Biobanking Market Analysis by End-users

8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Biobanking Market Size Estimation and Forecast by End-users
8.4 Pharmaceutical & Biotechnology Companies
8.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
8.4.2 Market Share by Region, 2024 & 2034 (%)
8.5 CROs
8.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
8.5.2 Market Share by Region, 2024 & 2034 (%)
8.6 Academic & Research Institutes
8.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
8.6.2 Market Share by Region, 2024 & 2034 (%)
8.7 Hospitals
8.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Biobanking Market Analysis by Region

9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Biobanking Market Analysis

10.1 Key Findings
10.2 North America Biobanking Market Attractiveness Index
10.3 North America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 North America Biobanking Market Size Estimation and Forecast by Country
10.5 North America Biobanking Market Size Estimation and Forecast by Ownership
10.6 North America Biobanking Market Size Estimation and Forecast by Sample
10.7 North America Biobanking Market Size Estimation and Forecast by Application
10.8 North America Biobanking Market Size Estimation and Forecast by Product and Service
10.9 North America Biobanking Market Size Estimation and Forecast by End-users
10.10 U.S. Biobanking Market Analysis
10.11 Canada Biobanking Market Analysis

11 Europe Biobanking Market Analysis

11.1 Key Findings
11.2 Europe Biobanking Market Attractiveness Index
11.3 Europe Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Europe Biobanking Market Size Estimation and Forecast by Country
11.5 Europe Biobanking Market Size Estimation and Forecast by Ownership
11.6 Europe Biobanking Market Size Estimation and Forecast by Sample
11.7 Europe Biobanking Market Size Estimation and Forecast by Application
11.8 Europe Biobanking Market Size Estimation and Forecast by Product and Service
11.9 Europe Biobanking Market Size Estimation and Forecast by End-users
11.10 Germany Biobanking Market Analysis
11.11 UK Biobanking Market Analysis
11.12 France Biobanking Market Analysis
11.13 Italy Biobanking Market Analysis
11.14 Spain Biobanking Market Analysis
11.15 Russia Biobanking Market Analysis
11.16 Rest of Europe Biobanking Market Analysis

12 Asia Pacific Biobanking Market Analysis

12.1 Key Findings
12.2 Asia Pacific Biobanking Market Attractiveness Index
12.3 Asia Pacific Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 Asia Pacific Biobanking Market Size Estimation and Forecast by Country
12.5 Asia Pacific Biobanking Market Size Estimation and Forecast by Ownership
12.6 Asia Pacific Biobanking Market Size Estimation and Forecast by Sample
12.7 Asia Pacific Biobanking Market Size Estimation and Forecast by Application
12.8 Asia Pacific Biobanking Market Size Estimation and Forecast by Product and Service
12.9 Asia Pacific Biobanking Market Size Estimation and Forecast by End-users
12.10 Japan Biobanking Market Analysis
12.11 China Biobanking Market Analysis
12.12 India Biobanking Market Analysis
12.13 Australia Biobanking Market Analysis
12.14 South Korea Biobanking Market Analysis
12.15 South-East Asia Biobanking Market Analysis
12.16 Rest of Asia Pacific Biobanking Market Analysis

13 Latin America Biobanking Market Analysis

13.1 Key Findings
13.2 Latin America Biobanking Market Attractiveness Index
13.3 Latin America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
13.4 Latin America Biobanking Market Size Estimation and Forecast by Country
13.5 Latin America Biobanking Market Size Estimation and Forecast by Ownership
13.6 Latin America Biobanking Market Size Estimation and Forecast by Sample
13.7 Latin America Biobanking Market Size Estimation and Forecast by Application
13.8 Latin America Biobanking Market Size Estimation and Forecast by Product and Service
13.9 Latin America Biobanking Market Size Estimation and Forecast by End-users
13.10 Brazil Biobanking Market Analysis
13.11 Mexico Biobanking Market Analysis
13.12 Rest of Latin America Biobanking Market Analysis

14 MEA Biobanking Market Analysis

14.1 Key Findings
14.2 MEA Biobanking Market Attractiveness Index
14.3 MEA Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
14.4 MEA Biobanking Market Size Estimation and Forecast by Country
14.5 MEA Biobanking Market Size Estimation and Forecast by Ownership
14.6 MEA Biobanking Market Size Estimation and Forecast by Sample
14.7 MEA Biobanking Market Size Estimation and Forecast by Application
14.8 MEA Biobanking Market Size Estimation and Forecast by Product and Service
14.9 MEA Biobanking Market Size Estimation and Forecast by End-users
14.10 GCC Biobanking Market Analysis
14.11 South Africa Biobanking Market Analysis
14.12 Rest of MEA Biobanking Market Analysis

15 Company Profiles

15.1 Thermo Fisher Scientific, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.3.1 Net Revenue, 2015-2022
15.1.3.2 Regional Market Shares, 2022
15.1.3.3 R&D, 2015-2022
15.1.4 Product Benchmarking
15.2 PHC Holdings Corporation
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Product Benchmarking
15.2.4 Strategic Outlook
15.3 Hamilton Company
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Product Benchmarking
15.4 Avantor Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2015-2022
15.4.3.2 Regional Market Shares, 2022
15.4.4 Product Benchmarking
15.5 Qiagen N.V.
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2015-2022
15.5.3.2 Regional Market Shares, 2022
15.5.3.3 R&D, 2015-2022
15.5.4 Product Benchmarking
15.6 Tecan Trading AG
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Product Benchmarking
15.7 Merck & Co., Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2015-2022
15.7.3.2 Regional Market Shares, 2022
15.7.3.3 R&D, 2015-2022
15.7.4 Product Benchmarking
15.8 Cryoport Inc.
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2015-2022
15.8.3.2 Regional Market Shares, 2022
15.8.3.3 R&D, 2015-2022
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Azenta Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2015-2022
15.9.3.2 R&D, 2015-2022
15.9.4 Product Benchmarking
15.10 Isenet Biobanking
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Product Benchmarking
15.11 CTI Biotech
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Product Benchmarking
15.12 Boca Biolistics
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Product Benchmarking
15.12.4 Strategic Outlook
15.13 BIOIVT & ELEVATING SCIENCE
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Product Benchmarking
15.13.4 Strategic Outlook
15.14 US Biolab Corp. Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Product Benchmarking
15.15 ProteoGenex Inc.
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Product Benchmarking
15.16 ASKION GmbH
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking

16 Conclusion and Recommendations

16.1 Concluding Remarks
16.2 Recommendations for Market Players

List of Tables

Table 1 Biobanking Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 7 National/Regional Agencies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Universities Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Non-profit Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Private Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Blood Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Human Tissues Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Nucleic Acid Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Biological Fluids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 17 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 Regenerative Medicine Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Life Science Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Clinical Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Software Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 CROs Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 North America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 North America Biobanking Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 North America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 36 North America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 37 North America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 North America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 U.S. Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Canada Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Europe Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Europe Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Europe Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Europe Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Europe Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Europe Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Germany Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 UK Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 France Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 Italy Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 Spain Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Russia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Rest of Europe Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Asia Pacific Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 Asia Pacific Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Asia Pacific Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Asia Pacific Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Japan Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 China Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 India Biobanking Institutes
Table 63 India Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Australia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 South Korea Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 South-East Asia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 Rest of Asia Pacific Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 Latin America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Latin America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 70 Latin America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 71 Latin America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 72 Latin America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 73 Latin America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 74 Brazil Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 75 Mexico Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 76 Rest of Latin America Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 77 MEA Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 78 MEA Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 79 MEA Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 80 MEA Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 81 MEA Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 82 MEA Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 83 GCC Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 84 South Africa Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 85 Rest of MEA Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 86 Thermo Fisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Thermo Fisher Scientific, Inc.: Product Benchmarking
Table 88 PHC Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 PHC Holdings Corporation: Product Benchmarking
Table 90 PHC Holdings Corporation: Strategic Outlook
Table 91 Hamilton Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Hamilton Company: Product Benchmarking
Table 93 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Avantor Inc.: Product Benchmarking
Table 95 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Qiagen N.V.: Product Benchmarking
Table 97 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Tecan Trading AG: Product Benchmarking
Table 99 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Merck & Co., Inc.: Product Benchmarking
Table 101 Cryoport Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Cryoport Inc.: Product Benchmarking
Table 103 Cryoport Inc.: Strategic Outlook
Table 104 Azenta Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Azenta Inc.: Product Benchmarking
Table 106 Isenet Biobanking: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Isenet Biobanking: Product Benchmarking
Table 108 CTI Biotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 CTI Biotech: Product Benchmarking
Table 110 Boca Biolistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Boca Biolistics: Product Benchmarking
Table 112 Boca Biolistics: Strategic Outlook
Table 113 BIOIVT & ELEVATING SCIENCE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 BIOIVT & ELEVATING SCIENCE: Product Benchmarking
Table 115 BIOIVT & ELEVATING SCIENCE: Strategic Outlook
Table 116 US Biolab Corp. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 US Biolab Corp. Inc.: Product Benchmarking
Table 118 ProteoGenex Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 ProteoGenex Inc.: Product Benchmarking
Table 120 ASKION GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 ASKION GmbH: Product Benchmarking

List of Figures

Figure 1 Biobanking Market Segmentation
Figure 2 Biobanking Market by Ownership: Market Attractiveness Index
Figure 3 Biobanking Market by Sample: Market Attractiveness Index
Figure 4 Biobanking Market by Application: Market Attractiveness Index
Figure 5 Biobanking Market by Product and Service: Market Attractiveness Index
Figure 6 Biobanking Market by End-users: Market Attractiveness Index
Figure 7 Biobanking Market Attractiveness Index by Region
Figure 8 Biobanking Market: Market Dynamics
Figure 9 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 10 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 11 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 12 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 13 Biobanking Market: Porter’s Five Forces Analysis
Figure 14 Biobanking Market: PEST Analysis
Figure 15 Biobanking Market Attractiveness Index by Ownership
Figure 16 Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
Figure 17 Biobanking Market Share Forecast by Ownership, 2024, 2029, 2034 (%)
Figure 18 National/Regional Agencies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 19 National/Regional Agencies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Universities Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 21 Universities Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Non-profit Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Non-profit Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Private Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 25 Private Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Biobanking Market Attractiveness Index by Ownership
Figure 27 Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
Figure 28 Biobanking Market Share Forecast by Sample, 2024, 2029, 2034 (%)
Figure 29 Blood Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Blood Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Human Tissues Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 32 Human Tissues Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Nucleic Acids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 34 Nucleic Acids Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 36 Cell Lines Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Biological Fluids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Biological Fluids Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 40 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Biobanking Market Attractiveness Index by Application
Figure 42 Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 43 Biobanking Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 44 Regenerative Medicine Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 45 Regenerative Medicine Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Life Science Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Life Science Research Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Clinical Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Clinical Research Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Biobanking Market Attractiveness Index by Product and Service
Figure 51 Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
Figure 52 Biobanking Market Share Forecast by Product and Service, 2024, 2029, 2034 (%)
Figure 53 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 54 Equipment Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 56 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 57 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 58 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 59 Software Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 60 Software Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 61 Biobanking Market Attractiveness Index by End-users
Figure 62 Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 63 Biobanking Market Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 64 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 65 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 66 CROs Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 67 CROs Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 68 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 69 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 70 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 71 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Biobanking Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
Figure 73 Biobanking Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 74 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 75 North America Biobanking Market Attractiveness Index
Figure 76 North America Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 77 North America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 78 North America Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
Figure 79 North America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
Figure 80 North America Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
Figure 81 North America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
Figure 82 North America Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
Figure 83 North America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 84 North America Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
Figure 85 North America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
Figure 86 North America Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
Figure 87 North America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 88 North America Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 89 U.S. Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 90 Canada Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 91 Europe Biobanking Market Attractiveness Index
Figure 92 Europe Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 93 Europe Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 94 Europe Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
Figure 95 Europe Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
Figure 96 Europe Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
Figure 97 Europe Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
Figure 98 Europe Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
Figure 99 Europe Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 100 Europe Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
Figure 101 Europe Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
Figure 102 Europe Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
Figure 103 Europe Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 104 Europe Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 105 Germany Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 106 UK Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 107 France Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 108 Italy Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Spain Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Russia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 111 Rest of Europe Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 Asia Pacific Biobanking Market Attractiveness Index
Figure 113 Asia Pacific Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 114 Asia Pacific Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 115 Asia Pacific Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
Figure 116 Asia Pacific Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
Figure 117 Asia Pacific Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
Figure 118 Asia Pacific Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
Figure 119 Asia Pacific Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
Figure 120 Asia Pacific Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 121 Asia Pacific Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
Figure 122 Asia Pacific Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
Figure 123 Asia Pacific Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
Figure 124 Asia Pacific Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 125 Asia Pacific Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 126 Japan Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 127 China Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 India Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 129 Australia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 130 South Korea Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 131 South-East Asia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 132 Rest of Asia Pacific Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 133 Latin America Biobanking Market Attractiveness Index
Figure 134 Latin America Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 135 Latin America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 136 Latin America Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
Figure 137 Latin America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
Figure 138 Latin America Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
Figure 139 Latin America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
Figure 140 Latin America Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
Figure 141 Latin America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 142 Latin America Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
Figure 143 Latin America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
Figure 144 Latin America Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
Figure 145 Latin America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 146 Latin America Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 147 Brazil Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 148 Mexico Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 149 Rest of Latin America Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 150 MEA Biobanking Market Attractiveness Index
Figure 151 MEA Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 152 MEA Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 153 MEA Biobanking Market Share Forecast by Country, 2024 & 2034 (%)
Figure 154 MEA Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)
Figure 155 MEA Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)
Figure 156 MEA Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)
Figure 157 MEA Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)
Figure 158 MEA Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 159 MEA Biobanking Market Share Forecast by Application, 2024 & 2034 (%)
Figure 160 MEA Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)
Figure 161 MEA Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)
Figure 162 MEA Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 163 MEA Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 164 GCC Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 165 South Africa Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 166 Rest of MEA Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 167 Thermo Fisher Scientific, Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 168 Thermo Fisher Scientific, Inc.: Regional Market Shares (%), 2022
Figure 169 Thermo Fisher Scientific, Inc.: R&D, 2015-2022 (US$ Million, AGR%)
Figure 170 Avantor Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 171 Avantor Inc.: Regional Market Shares (%), 2022
Figure 172 Qiagen N.V.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 173 Qiagen N.V.: Regional Market Shares (%), 2022
Figure 174 Qiagen N.V.: R&D, 2015-2022 (US$ Million, AGR%)
Figure 175 Merck & Co., Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 176 Merck & Co., Inc.: Regional Market Shares (%), 2022
Figure 177 Merck & Co., Inc.: R&D, 2015-2022 (US$ Million, AGR%)
Figure 178 Cryoport Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 179 Cryoport Inc.: Regional Market Shares (%), 2022
Figure 180 Cryoport Inc.: R&D, 2015-2022 (US$ Million, AGR%)
Figure 181 Azenta Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 182 Azenta Inc.: R&D, 2015-2022 (US$ Million, AGR%)

Companies Mentioned

ASKION GmbH
Avantor Inc.
Azenta Inc.
Boca Biolistics
BIOIVT & ELEVATING SCIENCE
Cryoport Inc.
CTI Biotech
Hamilton Company
Isenet Biobanking
Merck & Co., Inc.
PHC Holdings Corporation
ProteoGenex Inc.
Qiagen N.V.
Thermo Fisher Scientific, Inc.
Tecan Trading AG
US Biolab Corp. Inc.
BC Platforms (BCP)
BioGrad
Crown Bioscience
DNAnexus, Inc.
Indivumed GmbH
JSR Life Sciences
Lifebit
Omica.bio
SomaLogic, Inc.
SOMOS
American Association of Tissue Banks
Australasian Biospecimen Network (ABN)
China Kadoorie Biobank (CKB)
Chinese University of Hong Kong (CUHK)
European Association for Predictive, Preventative & Personalised Medicine (EPMA)
Food and Drug Administration (FDA)
Leiden University Medical Center (LUMC)
National Cancer Institute (NCI)
National Genome Research Network (NGFN)
Office of Biorepositories and Biospecimen Research (OBBR)
Russian Society for Biobanking and Biopreservation (RSBB)
Singapore Biobank (SBB)
Singapore Tissue Network (STN)
Spanish National Biobank Network
The Organisation for Economic Co-operation and Development (OECD)
UK Biobank
World Health Organization (WHO)

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5393EUR$5,713USD£4,350GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6385EUR$6,764USD£5,150GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7501EUR$7,946USD£6,050GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9478EUR$10,040USD£7,645GBP